TRF Pharma is a hematology and oncology focused comapny, developing therapies to treat diseases of abberrant cell adhesion to endothelial (blood vessel) walls. Its programs in sickle cell disease and cancer metastasis are based on heparin derivatives and heparinoid drugs.